期刊
ONCOIMMUNOLOGY
卷 1, 期 1, 页码 94-96出版社
LANDES BIOSCIENCE
DOI: 10.4161/onci.1.1.17885
关键词
chemotherapy; necrosis; HMGB1; innate immunity; tumor associated macrophage
资金
- NCI NIH HHS [R01 CA129536] Funding Source: Medline
- NIGMS NIH HHS [R01 GM097355] Funding Source: Medline
- NATIONAL CANCER INSTITUTE [R01CA129536] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097355] Funding Source: NIH RePORTER
The mechanism of tumor cell death after treatment with DNA alkylating agents in vivo previously remained largely unknown. We demonstrate that tumor regression after chemotherapy occurs via sporadic necrosis and relies on activation of innate immunity in a manner dependent on high mobility group box 1 protein (HMGB1).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
